Amaran Moodley1, Min Qin, Kumud K Singh, Stephen A Spector. 1. From the *University of California, San Diego; †Rady Children's Hospital, San Diego, CA; and ‡Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA.
Abstract
BACKGROUND: Vitamin D deficiency is common in HIV infection and has been associated with advanced disease. This study investigated whether vitamin D-related genetic variants were associated with disease progression in HIV-infected children. METHODS: The Fok-I (C/T), Bsm-I (G/A), GC (A/C), DHCR7 (G/T) and CYP2R1 (G/A) genetic variants were detected by real-time polymerase chain reaction in HIV-infected children who participated in the Pediatric AIDS Clinical Trials Group P152 and P300 protocols, which predated the availability of effective combination antiretroviral therapy. The primary endpoints included time to progression to the first HIV-related disease endpoint (≥2 opportunistic infection, weight growth failure) or death, which constituted the progression-free survival. Analyses were performed for age>2 years and ≤2 years separately adjusting for race and treatment effect. RESULTS: Of the 998 children evaluated, 139 experienced HIV disease progression. For children>2 years, rapid disease progression was associated with the DHCR7 G allele compared with the T allele (G/G vs. T/T: hazard ratio [HR]=5.0, P = 0.035; G/T vs. T/T: HR=4.5, P=0.042; G/G+G/T vs. T/T: HR=4.8, P=0.036) and the Bsm-I A allele compared with the G allele (A/G vs. G/G: HR=2.2, P=0.014 and A/G+A/A vs. G/G: HR=2.0, P=0.026). In children≤2 years, the Bsm-I A allele increased the risk of disease progression in Hispanics (A/A vs. G/A+G/G: HR=2.8, P=0.03 and A/A vs. G/G: HR=2.8, P=0.046) and whites (A/A vs. G/G: HR=6.6, P=0.025 and A/A vs. G/A+G/G: HR=3.6, P=0.038). CONCLUSIONS: Vitamin D-related host genetic variants that alter the availability and activity of vitamin D are associated with risk of HIV disease progression in children and may vary by age and race.
BACKGROUND:Vitamin D deficiency is common in HIV infection and has been associated with advanced disease. This study investigated whether vitamin D-related genetic variants were associated with disease progression in HIV-infectedchildren. METHODS: The Fok-I (C/T), Bsm-I (G/A), GC (A/C), DHCR7 (G/T) and CYP2R1 (G/A) genetic variants were detected by real-time polymerase chain reaction in HIV-infectedchildren who participated in the Pediatric AIDS Clinical Trials Group P152 and P300 protocols, which predated the availability of effective combination antiretroviral therapy. The primary endpoints included time to progression to the first HIV-related disease endpoint (≥2 opportunistic infection, weight growth failure) or death, which constituted the progression-free survival. Analyses were performed for age>2 years and ≤2 years separately adjusting for race and treatment effect. RESULTS: Of the 998 children evaluated, 139 experienced HIV disease progression. For children>2 years, rapid disease progression was associated with the DHCR7 G allele compared with the T allele (G/G vs. T/T: hazard ratio [HR]=5.0, P = 0.035; G/T vs. T/T: HR=4.5, P=0.042; G/G+G/T vs. T/T: HR=4.8, P=0.036) and the Bsm-I A allele compared with the G allele (A/G vs. G/G: HR=2.2, P=0.014 and A/G+A/A vs. G/G: HR=2.0, P=0.026). In children≤2 years, the Bsm-I A allele increased the risk of disease progression in Hispanics (A/A vs. G/A+G/G: HR=2.8, P=0.03 and A/A vs. G/G: HR=2.8, P=0.046) and whites (A/A vs. G/G: HR=6.6, P=0.025 and A/A vs. G/A+G/G: HR=3.6, P=0.038). CONCLUSIONS:Vitamin D-related host genetic variants that alter the availability and activity of vitamin D are associated with risk of HIV disease progression in children and may vary by age and race.
Authors: Laura Helming; Jens Böse; Jan Ehrchen; Stefanie Schiebe; Thomas Frahm; Robert Geffers; Michael Probst-Kepper; Rudi Balling; Andreas Lengeling Journal: Blood Date: 2005-08-23 Impact factor: 22.113
Authors: Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin Journal: Science Date: 2006-02-23 Impact factor: 47.728
Authors: Evelyne van Etten; Lieve Verlinden; Annapaula Giulietti; Elizabeth Ramos-Lopez; Dumitru D Branisteanu; Gabriela B Ferreira; Lut Overbergh; Annemieke Verstuyf; Roger Bouillon; Bart O Roep; Klaus Badenhoop; Chantal Mathieu Journal: Eur J Immunol Date: 2007-02 Impact factor: 5.532
Authors: Charles B Stephensen; Grace S Marquis; Laurie A Kruzich; Steven D Douglas; Grace M Aldrovandi; Craig M Wilson Journal: Am J Clin Nutr Date: 2006-05 Impact factor: 7.045
Authors: J A Englund; C J Baker; C Raskino; R E McKinney; B Petrie; M G Fowler; D Pearson; A Gershon; G D McSherry; E J Abrams; J Schliozberg; J L Sullivan Journal: N Engl J Med Date: 1997-06-12 Impact factor: 91.245
Authors: R E McKinney; G M Johnson; K Stanley; F H Yong; A Keller; K J O'Donnell; P Brouwers; W G Mitchell; R Yogev; D W Wara; A Wiznia; L Mofenson; J McNamara; S A Spector Journal: J Pediatr Date: 1998-10 Impact factor: 4.406
Authors: Adrian R Martineau; Katalin A Wilkinson; Sandra M Newton; R Andres Floto; Anthony W Norman; Keira Skolimowska; Robert N Davidson; Ole E Sørensen; Beate Kampmann; Christopher J Griffiths; Robert J Wilkinson Journal: J Immunol Date: 2007-06-01 Impact factor: 5.422
Authors: Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello Journal: Ital J Pediatr Date: 2018-05-08 Impact factor: 2.638
Authors: Christopher R Sudfeld; Christopher Duggan; Said Aboud; Roland Kupka; Karim P Manji; Rodrick Kisenge; Wafaie W Fawzi Journal: J Nutr Date: 2014-11-12 Impact factor: 4.798
Authors: Briony F Hudson; Linda Jm Oostendorp; Bridget Candy; Victoria Vickerstaff; Louise Jones; Monica Lakhanpaul; Myra Bluebond-Langner; Paddy Stone Journal: Palliat Med Date: 2016-09-08 Impact factor: 4.762
Authors: María Ángeles Jiménez-Sousa; José Luis Jiménez; Amanda Fernández-Rodríguez; José María Bellón; Carmen Rodríguez; Melchor Riera; Joaquín Portilla; Ángeles Castro; María Ángeles Muñoz-Fernández; Salvador Resino Journal: J Biomed Sci Date: 2019-10-23 Impact factor: 8.410
Authors: Salvador Resino; María Ángeles Jiménez-Sousa; Julià Blanco; Yolanda M Pacheco; Jorge Del Romero; Joaquim Peraire; Ana Virseda-Berdices; María José Muñoz-Gómez; Carlos Galera-Peñaranda; Lucio Jesus García-Fraile; José M Benito; Norma Rallón Journal: Front Pharmacol Date: 2022-01-18 Impact factor: 5.810